This inventor holds 5 USPTO granted patents and 4 published patent applications, plus 3 CIPO patents and 2 EPO patents. Top assignee: Genentech, Inc.. Active years: 2017-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Redwood City, CA (US) (2017 - 2022)
- Cupertino, CA (US) (2022)
Company Filing History:
Years Active: 2017-2026
Title: Innovator Spotlight: Yanan Zheng
Introduction
Yanan Zheng is an accomplished inventor based in Redwood City, California, known for her significant contributions to the field of therapeutic treatments. With a remarkable four patents under her name, Yanan has made strides in addressing various health conditions, particularly those related to the immune system.
Latest Patents
Among her latest innovations, Yanan Zheng has focused on the therapeutic uses of IL-13 antagonists for treating atopic dermatitis. Her patented methods include strategies for reducing the severity of atopic dermatitis through the administration of IL-13 antagonists. Additionally, Yanan has developed methods for treating asthma by utilizing IL-13 antibodies, providing innovative solutions for diagnosing and treating disorders related to TH2 inhibition.
Career Highlights
Yanan Zheng is a key member of Genentech, Inc., a leading biotechnology company recognized for its groundbreaking work in pharmaceutical innovations. Her work there underscores her commitment to advancing medical treatments and improving patient outcomes through research and development.
Collaborations
Throughout her career, Yanan has collaborated with prominent colleagues, including Joseph R. Arron and Richard W. Erickson. These collaborations highlight her ability to work effectively within multidisciplinary teams and contribute to advancements in medical research.
Conclusion
Yanan Zheng's remarkable achievements as an inventor reflect her dedication to medical innovation and her impact on the treatment of complex health conditions. Her work continues to inspire advancements in therapeutic methodologies, making her a valuable asset in the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile